Hui Miao
Director/Board Member bei Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Profil
Hui Miao is currently the Director at Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Prior to this, Mr. Miao served as the President, Chief Executive Officer & Director at GuangYuYuan Chinese Herbal Medicine Co., Ltd.
from 2022 to 2024.
Mr. Miao completed their undergraduate degree at Renmin University of China.
Aktive Positionen von Hui Miao
Unternehmen | Position | Beginn |
---|---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The private company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Director/Board Member | - |
Ehemalige bekannte Positionen von Hui Miao
Unternehmen | Position | Ende |
---|---|---|
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Chief Executive Officer | 09.04.2024 |
Ausbildung von Hui Miao
Renmin University of China | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
GUANGYUYUAN CHINESE HERBAL MEDICINE CO., LTD. | Health Technology |
Private Unternehmen | 1 |
---|---|
Beijing Zhendong Langdi Pharmaceutical Co., Ltd.
Beijing Zhendong Langdi Pharmaceutical Co., Ltd. Pharmaceuticals: OtherHealth Technology Part of Fountainvest Partners (Asia) Ltd., Beijing Zhendong Langdi Pharmaceutical Co., Ltd. manufactures medicinal chemicals and botanical products. The private company is based in Beijing, China. Beijing Zhendong Langdi Pharmaceutical Co. was acquired by Shanghai Fanglang Enterprise Management Co. Ltd. from Shanxi Zhendong Pharmaceutical Co., Ltd. on October 28, 2021 for $895.09 million. The Chinese company was founded in 2003. | Health Technology |